LNSR LENSAR, Inc. - Common Stock
NASDAQ · Health Care · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 13, 2026
$6,75
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$4,95Bas 52 semaines
$12,84Haut 52 semaines
Capitalisation Boursière (MRQ)
$83M
P/E (TTM)
-22.5
BPA (TTM)
$-0.30
Revenu (TTM)
$60M
vos badges
Fourchette 52 semaines
$5–$13
Note des analystes
BUY
Objectif de cours
$11
P/E
-22.5
ROE
-851.7%
Marge nette
57.6%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
LNSR Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$6.75
Capitalisation Boursière (MRQ)
$83M
P/E (TTM)
-22.5
BPA (TTM)
$-0.30
Revenu (TTM)
$60M
ROE (TTM)
-851.7%
Fourchette 52 semaines
$5–$13
LNSR Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$58M2019-12-31 → 2025-12-31
BPA$-2.872021-12-31 → 2025-12-31
Flux de trésorerie libre·2020-12-31 → 2023-12-31
Marge nette57.6%2020-12-31 → 2023-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | LNSR | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -22.5moyenne 5 ans ≈-2.9 | ≈-2.9 | · | · | |
| P/S (TTM) | 1.4moyenne 5 ans ≈1.3 | ≈1.3 | 2.1 | Sous-évalué | |
| P/B (MRQ) | 5.6moyenne 5 ans ≈1.1 | ≈1.1 | 2.7 | Surévalué | |
| Cours / Actif net tangible (MRQ) | 8.2moyenne 5 ans ≈1.5 | ≈1.5 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | LNSR | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge d'exploitation (TTM) | -13.5%moyenne 5 ans ≈-47.7% | ≈-47.7% | -39.8% | Premier rang | |
| Marge nette (TTM) | 57.6%moyenne 5 ans ≈-49.1% | ≈-49.1% | -44.3% | Premier rang | |
| ROA (TTM) | 49.6%moyenne 5 ans ≈-27.5% | ≈-27.5% | -43.4% | En ligne | |
| ROE (TTM) | -851.7%moyenne 5 ans ≈-41.1% | ≈-41.1% | -41.2% | Premier rang |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | LNSR | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Ratio de liquidité (MRQ) | 2.4moyenne 5 ans ≈4.0 | ≈4.0 | 3.8 | Faible liquidité | |
| Ratio de liquidité réduite (MRQ) | 1.0moyenne 5 ans ≈2.8 | ≈2.8 | 3.2 | Faible liquidité |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | LNSR | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | 9.2%moyenne 5 ans ≈17.7% | ≈17.7% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 18.2%moyenne 5 ans ≈17.0% | ≈17.0% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 17.2% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | LNSR | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$389.6K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-393.8%
Prochain rapport
Nov 04, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 13, 2026 | $0.10 | $-0.17 | 159.4% |
| 31 mars 2026 | $0.00 | $0.19 | -100.0% | |
| 31 décembre 2025 | $-0.12 | $-0.07 | -68.1% | |
| 30 septembre 2025 | $-0.31 | $-0.05 | -507.8% | |
| 30 juin 2025 | $-0.15 | $-0.08 | -96.1% | |
| 31 mars 2025 | $-2.32 | $-0.16 | -1367.4% | |
| 31 décembre 2024 | $-1.61 | $-0.18 | -776.9% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $58M | $53M | $42M | $35M | $34M | $26M | $31M | |
| Cost of Revenue | $31M | $28M | $21M | $15M | $17M | $12M | $17M | |
| R&D Expense | $6M | $5M | $6M | $12M | $12M | $8M | $8M | |
| SG&A Expense | $45M | $26M | $26M | $27M | $24M | $24M | $17M | |
| Operating Income | $-25M | $-11M | $-12M | $-20M | $-20M | $-19M | $-13M | |
| Interest Expense | · | · | · | · | · | $1M | $2M | |
| Other Non-op | $636.0K | $660.0K | $698.0K | $263.0K | $51.0K | $68.0K | $58.0K | |
| Pretax Income | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | $-15M | |
| Net Income | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | $-15M | |
| EPS (Basic) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · | |
| EPS (Diluted) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · | |
| Shares (Basic) | 11,958,000 | 11,518,000 | 10,971,000 | 10,159,000 | 9,374,000 | · | · | |
| Shares (Diluted) | 11,958,000 | 11,518,000 | 10,971,000 | 10,159,000 | 9,374,000 | · | · | |
| EBITDA | · | · | $-12M | $-20M | $-20M | $-19M | · |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $16M | $21M | $15M | $32M | $41M | $5M | |
| Short-term Investments | $5M | $6M | $3M | · | · | · | · | |
| Receivables | $6M | $6M | $4M | $6M | $5M | $2M | $3M | |
| Inventory | $22M | $11M | $16M | $12M | $6M | $13M | $8M | |
| Prepaid Expense | $601.0K | $2M | $2M | $1M | $2M | $2M | $618.0K | |
| Current Assets | $47M | $42M | $46M | $34M | $45M | $58M | $17M | |
| PP&E (Net) | $505.0K | $664.0K | $679.0K | $563.0K | $756.0K | $832.0K | $720.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | $5M | $6M | $11M | $12M | $11M | $12M | $13M | |
| Other Non-current Assets | $3M | $3M | $2M | $3M | $3M | $4M | $1M | |
| Total Assets | $71M | $66M | $70M | $56M | $66M | $79M | $35M | |
| Accounts Payable | $19M | $6M | $4M | $5M | $3M | $2M | $2M | |
| Accrued Liabilities | $8M | $7M | $6M | $5M | $5M | $5M | $5M | |
| Current Liabilities | $41M | $15M | $12M | $11M | $9M | $8M | $8M | |
| Capital Leases | $2M | $2M | $2M | $2M | $3M | $3M | $333.0K | |
| Other Non-current Liabilities | $909.0K | $702.0K | $570.0K | $167.0K | $69.0K | $129.0K | $310.0K | |
| Total Liabilities | $84M | $48M | $22M | $14M | $12M | $12M | $65M | |
| Common Stock | $120.0K | $116.0K | $113.0K | $111.0K | $110.0K | $109.0K | $11.0K | |
| Retained Earnings | $-178M | $-143M | $-112M | $-98M | $-78M | $-58M | $-38M | |
| AOCI | $4.0K | $6.0K | $4.0K | · | · | · | · | |
| Stockholders' Equity | $-26M | $5M | $33M | $42M | $55M | $67M | $-31M | |
| Liabilities + Equity | $71M | $66M | $70M | $56M | $66M | $79M | $35M | |
| Shares Outstanding | 11,993,000 | 11,654,000 | 11,327,000 | 11,093,000 | 10,990,000 | 10,933,000 | 1,070,000 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $6M | $7M | $7M | $9M | $102.0K | |
| Amort. of Intangibles | $921.0K | $970.0K | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-2M | $-10M | $-15M | $-9M | $-14M | $-13M | |
| CapEx | $83.0K | $156.0K | $236.0K | $115.0K | $354.0K | $366.0K | $389.0K | |
| Investing Cash Flow | $1M | $-2M | $-4M | $-115.0K | $-354.0K | $-326.0K | $-2M | |
| Stock Issued | · | · | · | · | · | $16M | · | |
| Net Stock Activity | · | · | · | · | · | $16M | · | |
| Financing Cash Flow | $10M | $78.0K | $20M | $-2M | $361.0K | $50M | $16M | |
| Net Change in Cash | $-3M | $-4M | $6M | $-17M | $-9M | $36M | $1M | |
| Taxes Paid | $42.0K | $24.0K | $18.0K | $3.0K | $19.0K | · | · | |
| Free Cash Flow | · | · | $-10M | $-15M | $-9M | $-14M | · |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -29.0% | -57.1% | -57.0% | -70.1% | · | |
| Net Margin | · | · | -34.1% | -56.3% | -56.9% | -75.0% | · | |
| Pretax Margin | · | · | -34.1% | -56.3% | -56.9% | -75.0% | · | |
| EBITDA Margin | · | · | -29.0% | -57.1% | -57.0% | -70.1% | · | |
| ROA | · | · | -22.9% | -32.6% | -26.9% | -34.8% | · | |
| ROE | · | · | -41.2% | -47.1% | -35.0% | -29.0% | · |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 4.0 | 3.0 | 5.1 | 6.9 | · | |
| Quick Ratio | · | · | 2.4 | 1.8 | 4.2 | 5.0 | · | |
| Interest Coverage | · | · | · | · | · | -13.8 | · |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.7 | 0.6 | 0.5 | 0.5 | · | |
| Inventory Turnover | · | · | 1.5 | 1.7 | 1.7 | 1.1 | · | |
| Receivables Turnover | · | · | 8.4 | 6.6 | 10.4 | 9.8 | · |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | $2.95 | $3.78 | $4.99 | $6.15 | · | |
| Revenue / Share | · | · | $3.84 | $3.48 | · | · | · | |
| Cash Flow / Share | · | · | $-0.88 | $-1.46 | · | · | · | |
| Cash / Share | · | · | $1.82 | $1.32 | $2.88 | $3.71 | · | |
| EPS (TTM) | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 | · | · |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.2% | 26.9% | 19.2% | 2.6% | 30.6% | · | · | |
| Revenue CAGR 3Y | 18.2% | 15.8% | 16.9% | · | · | · | · | |
| Revenue CAGR 5Y | 17.2% | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $58M | $53M | $42M | $35M | $34M | $26M | · | |
| Net Income TTM | $-34M | $-31M | $-14M | $-20M | $-20M | $-20M | · | |
| Market Cap | · | · | $40M | $33M | $66M | $79M | · | |
| P/E | -4.1 | -3.3 | -2.7 | -1.5 | -2.9 | · | · | |
| P/S | · | · | 0.9 | 0.9 | 1.9 | 3.0 | · | |
| P/B | · | · | 1.2 | 0.8 | 1.2 | 1.2 | · | |
| P / Tangible Book | · | · | 1.8 | 1.1 | 1.5 | 1.4 | · | |
| P / Cash Flow | · | · | -4.1 | -2.2 | -7.3 | -5.7 | · | |
| P / FCF | · | · | -4.0 | -2.2 | -7.1 | -5.6 | · | |
| Earnings Yield | -24.7% | -30.5% | -37.3% | -66.2% | -34.9% | · | · |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16M | $13M | $16M | $14M | $14M | $14M | $17M | $14M | $13M | $11M | $12M | $10M | $12M | $8M | $10M | $8M | |
| Cost of Revenue | $7M | $7M | $9M | $8M | $7M | $7M | $10M | $7M | $6M | $5M | $7M | $5M | $5M | $4M | $4M | $4M | |
| R&D Expense | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $2M | |
| SG&A Expense | $6M | $3M | $10M | $12M | $12M | $11M | $7M | $6M | $7M | $7M | $6M | $5M | $8M | $7M | $7M | $6M | |
| Operating Income | $2M | $2M | $-5M | $-8M | $-6M | $-6M | $-1M | $-1M | $-5M | $-3M | $-3M | $-2M | $-3M | $-4M | $-3M | $-4M | |
| Other Non-op | $171.0K | $145.0K | $151.0K | $133.0K | $193.0K | $159.0K | $149.0K | $153.0K | $160.0K | $198.0K | $233.0K | $265.0K | $111.0K | $89.0K | $123.0K | $92.0K | |
| Income Tax | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income | $4M | $36M | $-1M | $-4M | $-2M | $-27M | $-19M | $-2M | $-9M | $-2M | $-4M | $3M | $-9M | $-4M | $-2M | $-4M | |
| EPS (Basic) | $0.14 | $1.56 | $-0.09 | $-0.31 | $-0.15 | $-2.32 | $-1.62 | $-0.13 | $-0.79 | $-0.19 | $-0.23 | $0.13 | $-0.81 | $-0.40 | $-0.23 | $-0.39 | |
| EPS (Diluted) | $0.10 | $0.00 | $-0.09 | $-0.31 | $-0.15 | $-2.32 | $-1.62 | $-0.13 | $-0.79 | $-0.19 | $0.13 | $-0.23 | $-0.81 | $-0.40 | $-0.23 | $-0.39 | |
| Shares (Basic) | 12,297,000 | 12,161,000 | · | 12,044,000 | 11,937,000 | 11,774,000 | · | 11,604,000 | 11,451,000 | 11,387,000 | · | 11,102,000 | 10,820,000 | 10,716,000 | · | 10,225,000 | |
| Shares (Diluted) | 23,027,000 | 15,420,000 | · | 12,044,000 | 11,937,000 | 11,774,000 | · | 11,604,000 | 11,451,000 | 11,387,000 | · | 11,956,000 | 10,820,000 | 10,716,000 | · | 10,225,000 | |
| EBITDA | $2M | $2M | · | $-8M | $-6M | $-6M | · | $-1M | $-5M | $-3M | · | $-2M | $-3M | $-4M | · | $-4M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $14M | $12M | $13M | $8M | $7M | $20M | $16M | $10M | $8M | $14M | $21M | $25M | $25M | $8M | $15M | $19M | |
| Short-term Investments | $0 | $1M | $5M | $9M | $13M | $6M | $6M | $8M | $6M | $4M | $3M | · | · | · | · | · | |
| Receivables | $6M | $5M | $6M | $6M | $5M | $7M | $6M | $4M | $6M | $4M | $4M | $4M | $3M | $5M | $6M | $4M | |
| Inventory | $25M | $23M | $22M | $21M | $19M | $15M | $11M | $15M | $18M | $18M | $16M | $17M | $18M | $16M | $12M | $8M | |
| Prepaid Expense | $2M | $625.0K | $601.0K | $776.0K | $991.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Current Assets | $47M | $42M | $47M | $44M | $46M | $49M | $42M | $39M | $40M | $42M | $46M | $49M | $49M | $30M | $34M | $32M | |
| PP&E (Net) | $445.0K | $457.0K | $505.0K | $555.0K | $609.0K | $577.0K | $664.0K | $677.0K | $716.0K | $747.0K | $679.0K | $482.0K | $605.0K | $520.0K | $563.0K | $639.0K | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $11M | $11M | $11M | $12M | $12M | $12M | $12M | |
| Other Non-current Assets | $2M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| Total Assets | $70M | $66M | $71M | $70M | $70M | $73M | $66M | $62M | $61M | $66M | $70M | $71M | $71M | $52M | $56M | $55M | |
| Accounts Payable | $11M | $10M | $19M | $15M | $11M | $8M | $6M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | |
| Accrued Liabilities | $5M | $4M | $8M | $8M | $6M | $7M | $7M | $6M | $4M | $4M | $6M | $5M | $4M | $3M | $5M | $5M | |
| Current Liabilities | $20M | $18M | $41M | $36M | $30M | $27M | $15M | $12M | $10M | $10M | $12M | $11M | $11M | $10M | $11M | $10M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Liabilities | $874.0K | $815.0K | $909.0K | $911.0K | $544.0K | $616.0K | $702.0K | $205.0K | $262.0K | $537.0K | $570.0K | $560.0K | $568.0K | $360.0K | $167.0K | $22.0K | |
| Total Liabilities | $41M | $42M | $84M | $82M | $80M | $81M | $48M | $25M | $24M | $21M | $22M | $21M | $25M | $13M | $14M | $12M | |
| Common Stock | $123.0K | $121.0K | $120.0K | $119.0K | $119.0K | $118.0K | $116.0K | $116.0K | $115.0K | $114.0K | $113.0K | $112.0K | $112.0K | $111.0K | $111.0K | $110.0K | |
| Retained Earnings | $-138M | $-141M | $-178M | $-176M | $-172M | $-171M | $-143M | $-125M | $-123M | $-114M | $-112M | $-108M | $-111M | $-102M | $-98M | $-95M | |
| AOCI | $0 | $0 | $4.0K | $5.0K | $-3.0K | $3.0K | $6.0K | $15.0K | $-6.0K | $-1.0K | $4.0K | · | · | · | · | · | |
| Stockholders' Equity | $15M | $11M | $-26M | $-26M | $-23M | $-22M | $5M | $23M | $24M | $32M | $33M | $36M | $33M | $39M | $42M | $43M | |
| Liabilities + Equity | $70M | $66M | $71M | $70M | $70M | $73M | $66M | $62M | $61M | $66M | $70M | $71M | $71M | $52M | $56M | $55M | |
| Shares Outstanding | 12,282,000 | 12,101,000 | 11,993,000 | 11,935,000 | 11,933,000 | 11,790,000 | 11,654,000 | 11,612,000 | 11,544,000 | 11,395,000 | 11,327,000 | 11,246,000 | 11,199,000 | 11,103,000 | 11,093,000 | 11,023,000 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $347.0K | $690.0K | $873.0K | $850.0K | $766.0K | $654.0K | $662.0K | $668.0K | $683.0K | $652.0K | $816.0K | $1M | $2M | $2M | $2M | $2M | |
| Amort. of Intangibles | $228.0K | $229.0K | $230.0K | $229.0K | $230.0K | $232.0K | $232.0K | $232.0K | $232.0K | $274.0K | $273.0K | $273.0K | $275.0K | $276.0K | $276.0K | $276.0K | |
| Operating Cash Flow | $-127.0K | $-4M | $618.0K | $-4M | $-5M | $-7M | $4M | $3M | $-4M | $-5M | $-480.0K | $-339.0K | $-2M | $-7M | $-5M | $-5M | |
| CapEx | · | · | $0 | $0 | $77.0K | $6.0K | $3.0K | $20.0K | $113.0K | $20.0K | $45.0K | $2.0K | $181.0K | $8.0K | $57.0K | $2.0K | |
| Investing Cash Flow | $965.0K | $4M | $4M | $4M | $-7M | $531.0K | $2M | $-905.0K | $-2M | $-1M | $-4M | $-2.0K | $-181.0K | $-8.0K | $-57.0K | $-2.0K | |
| Financing Cash Flow | $233.0K | $-209.0K | $474.0K | $0 | $93.0K | $10M | $172.0K | $-93.0K | $129.0K | $-130.0K | $146.0K | $-205.0K | · | · | $196.0K | $-1M | |
| Net Change in Cash | $1M | $-480.0K | $5M | $487.0K | $-12M | $3M | $6M | $2M | $-6M | $-7M | $-4M | $-546.0K | $17M | $-7M | $-5M | $-6M | |
| Taxes Paid | · | · | $0 | · | · | · | $2.0K | $0 | · | · | $0 | $0 | $17.0K | $1.0K | $-7.0K | $0 | |
| Free Cash Flow | · | · | · | · | · | $-7M | · | · | · | $-5M | · | · | · | $-7M | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.9% | 16.7% | · | -52.9% | -45.1% | -40.9% | · | -9.2% | -41.8% | -26.9% | · | -20.8% | -23.9% | -52.8% | · | -52.7% | |
| Net Margin | 21.4% | 270.6% | · | -25.9% | -12.7% | -193.1% | · | -11.1% | -71.6% | -20.4% | · | 26.2% | -72.9% | -51.8% | · | -51.5% | |
| EBITDA Margin | 12.9% | 16.7% | · | -52.9% | -45.1% | -40.9% | · | -9.2% | -41.8% | -26.9% | · | -20.8% | -23.9% | -52.8% | · | -52.7% | |
| ROA | 5.1% | 52.2% | · | -5.6% | -2.7% | -39.3% | · | -2.3% | -13.6% | -3.6% | · | 4.1% | -13.5% | -7.6% | · | -6.5% | |
| ROE | -86.8% | -640.2% | · | 234.3% | -594.9% | -564.2% | · | -5.1% | -32.1% | -6.0% | · | 6.5% | -22.6% | -9.6% | · | -8.0% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.4 | · | 1.2 | 1.5 | 1.8 | · | 3.4 | 3.9 | 4.1 | · | 4.4 | 4.7 | 3.0 | · | 3.3 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.6 | 0.8 | 1.2 | · | 1.9 | 1.9 | 2.1 | · | 2.6 | 2.7 | 1.3 | · | 2.3 |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.0 | 2.3 | · | 2.8 | 2.6 | 2.6 | · | 3.3 | 2.8 | 2.4 | · | 2.6 | 4.0 | 2.0 | · | 2.4 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.21 | $0.89 | · | $-2.17 | $-1.93 | $-1.88 | · | $1.96 | $2.05 | $2.79 | · | $3.24 | $2.92 | $3.55 | · | $3.86 | |
| Revenue / Share | $0.72 | $0.87 | · | $1.19 | $1.17 | $1.20 | · | $1.17 | $1.10 | $0.93 | · | $0.82 | $1.11 | $0.77 | · | $0.76 | |
| Cash Flow / Share | · | $-0.28 | · | · | · | $-0.59 | · | · | · | $-0.47 | · | · | · | $-0.62 | · | · | |
| Cash / Share | $1.10 | $1.03 | · | $0.64 | $0.60 | $1.66 | · | $0.90 | $0.72 | $1.22 | · | $2.22 | $2.27 | $0.72 | · | $1.75 | |
| EPS (TTM) | $-0.30 | $-0.55 | · | $-4.40 | $-4.22 | $-4.86 | · | $-0.98 | $-1.08 | $-1.10 | · | $-1.67 | $-1.83 | $-1.69 | · | $-2.13 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $60M | $58M | · | $59M | $58M | $57M | · | $49M | $45M | $44M | · | $40M | $38M | $34M | · | $36M | |
| Net Income TTM | $35M | $29M | · | $-52M | $-49M | $-57M | · | $-17M | $-13M | $-12M | · | $-13M | $-20M | $-18M | · | $-21M | |
| Market Cap | $70M | $72M | · | $147M | $157M | $166M | · | $53M | $52M | $39M | · | $35M | $48M | $28M | · | $61M | |
| P/E | -19.0 | -10.8 | · | -2.8 | -3.1 | -2.9 | · | -4.7 | -4.2 | -3.1 | · | -1.9 | -2.3 | -1.5 | · | -2.6 | |
| P/S | 1.2 | 1.2 | · | 2.5 | 2.7 | 2.9 | · | 1.1 | 1.2 | 0.9 | · | 0.9 | 1.2 | 0.8 | · | 1.7 | |
| P/B | 4.7 | 6.7 | · | -5.7 | -6.8 | -7.5 | · | 2.3 | 2.2 | 1.2 | · | 1.0 | 1.5 | 0.7 | · | 1.4 | |
| P / Tangible Book | 6.9 | 12.4 | · | · | · | · | · | 3.2 | 3.0 | 1.8 | · | 1.4 | 2.3 | 1.0 | · | 2.0 | |
| P / Cash Flow | · | -16.9 | · | · | · | -24.0 | · | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| Earnings Yield | -5.2% | -9.2% | · | -35.6% | -32.0% | -34.4% | · | -21.4% | -24.0% | -32.4% | · | -54.0% | -43.1% | -67.9% | · | -38.4% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $58M | $53M | $42M | $35M | $34M |
| Marge d'exploitation % | · | · | -29.0% | -57.1% | -57.0% |
| Résultat net | $-34M | $-31M | $-14M | $-20M | $-20M |
| BPA dilué | $-2.87 | $-2.73 | $-1.31 | $-1.96 | $-2.09 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio de liquidité | · | · | 4.0 | 3.0 | 5.1 |
| Ratio de liquidité réduite | · | · | 2.4 | 1.8 | 4.2 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | · | · | $-10M | $-15M | $-9M |
Détenteurs institutionnels (13F) 81 déclarants · $31.0M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
81
Valeur détenue
$31.0M
Nouvelles positions
18
Positions clôturées
29
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 18 (-8 vs T. préc.) | 29 (+20 vs T. préc.) | 19 (-12 vs T. préc.) | 20 (+5 vs T. préc.) | -831K |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | $6 140 534 | 1 075 400 | 19,80% | Actions |
| VANGUARD GROUP INC | $5 997 881 | 515 725 | 19,34% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $2 300 022 | 402 806 | 7,42% | Actions |
| Groupe la Francaise | $1 219 296 | 213 537 | 3,93% | Actions |
| RBF Capital, LLC | $1 077 254 | 188 661 | 3,47% | Actions |
| BlackRock, Inc. | $1 056 539 | 185 033 | 3,41% | Actions |
| CSS LLC/IL | $933 300 | 163 450 | 3,01% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $865 687 | 151 609 | 2,79% | Actions |
| CREDIT INDUSTRIEL ET COMMERCIAL | $824 290 | 144 359 | 2,66% | Actions |
| Kerrisdale Advisers, LLC | $795 917 | 139 390 | 2,57% | Actions |
| MILLENNIUM MANAGEMENT LLC | $689 083 | 120 680 | 2,22% | Actions |
| DCF Advisers, LLC | $675 019 | 118 217 | 2,18% | Actions |
| Evernest Financial Advisors, LLC | $674 351 | 118 100 | 2,17% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $653 221 | 114 331 | 2,11% | Actions |
| UBS Group AG | $488 970 | 85 634 | 1,58% | Actions |
| Yakira Capital Management, Inc. | $475 574 | 83 288 | 1,53% | Actions |
| STATE STREET CORP | $462 413 | 80 983 | 1,49% | Actions |
| Man Group plc | $445 164 | 77 962 | 1,44% | Actions |
| Alpine Global Management, LLC | $340 139 | 59 569 | 1,10% | Actions |
| GOLDMAN SACHS GROUP INC | $339 911 | 59 529 | 1,10% | Actions |
| GABELLI FUNDS LLC | $336 890 | 59 000 | 1,09% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $330 215 | 57 831 | 1,07% | Actions |
| Dynamic Technology Lab Private Ltd | $309 000 | 54 166 | 1,00% | Actions |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $304 103 | 53 258 | 0,98% | Actions |
| Centiva Capital, LP | $281 229 | 49 252 | 0,91% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $252 696 | 44 255 | 0,81% | Actions |
| CITADEL ADVISORS LLC | $204 115 | 35 747 | 0,66% | Actions |
| CITADEL ADVISORS LLC | $203 276 | 35 600 | 0,66% | Option de vente |
| GAMCO INVESTORS, INC. ET AL | $188 430 | 33 000 | 0,61% | Actions |
| LPL Financial LLC | $180 824 | 31 668 | 0,58% | Actions |
| Quinn Opportunity Partners LLC | $167 583 | 29 349 | 0,54% | Actions |
| GTS SECURITIES LLC | $142 773 | 25 004 | 0,46% | Actions |
| Cresset Asset Management, LLC | $142 750 | 25 000 | 0,46% | Actions |
| ROYAL BANK OF CANADA | $134 000 | 23 464 | 0,43% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $133 169 | 23 322 | 0,43% | Actions |
| NORTHERN TRUST CORP | $125 717 | 22 017 | 0,41% | Actions |
| JANE STREET GROUP, LLC | $116 273 | 20 363 | 0,38% | Actions |
| Carlson Capital, L.P. | $114 200 | 20 000 | 0,37% | Actions |
| Qube Research & Technologies Ltd | $106 052 | 18 573 | 0,34% | Actions |
| Sanctuary Advisors, LLC | $95 911 | 16 797 | 0,31% | Actions |
| Atria Investments, Inc | $86 695 | 15 183 | 0,28% | Actions |
| Murchinson Ltd. | $75 503 | 13 223 | 0,24% | Actions |
| Engineers Gate Manager LP | $63 324 | 11 090 | 0,20% | Actions |
| JANE STREET GROUP, LLC | $62 810 | 11 000 | 0,20% | Option d'achat |
| &PARTNERS | $60 263 | 10 554 | 0,19% | Actions |
| Bank of New York Mellon Corp | $57 606 | 10 089 | 0,19% | Actions |
| Skandinaviska Enskilda Banken AB (publ) | $57 100 | 10 000 | 0,18% | Actions |
| Russell Investments Group, Ltd. | $56 204 | 9 843 | 0,18% | Actions |
| MORGAN STANLEY | $48 491 | 8 492 | 0,16% | Actions |
| FMR LLC | $18 209 | 3 189 | 0,06% | Actions |
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| North Run Capital, LP, North Run Advisors, LLC, NR-GRI Partners, LP, NR-GRI Partners GP, LP, ELLIS THOMAS B, HAMMER TODD B ×2 dépôts | 25 mars 2025 | 55,90% | Amendement | Fusions et acquisitions / vente | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 13 initiés · 4 dirigeants · 9 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Nicholas T Curtis | Chief Executive Officer | 3 juin 2026 A | 1 122 758 | 0 | 0 | $0 |
| Thomas R Staab II | Chief Financial Officer | 6 mai 2026 F | 174 609 | 0 | 0 | $0 |
| Alan B. Connaughton | Chief Operating Officer | 3 juin 2026 A | 389 173 | 0 | 0 | $0 |
| Kendra Wong | Principal Accounting Officer | 3 juin 2026 A | 56 481 | 0 | 0 | $0 |
| Gary M Winer | Administrateur | 3 juin 2026 A | 105 635 | 0 | 0 | $0 |
| Elizabeth G. O'Farrell | Administrateur | 3 juin 2026 A | 67 368 | 0 | 0 | $0 |
| HAMMER TODD B | Administrateur | 3 juin 2026 A | 56 083 | 0 | 0 | $0 |
| Thomas B Ellis | Administrateur | 3 juin 2026 A | 56 083 | 0 | 0 | $0 |
| Richard L Lindstrom MD | Administrateur | 3 juin 2026 A | 263 831 | 0 | 0 | $0 |
| William J Link PHD | Administrateur | 3 juin 2026 A | 568 062 | 0 | 0 | $0 |
| Aimee S Weisner | Administrateur | 3 juin 2026 A | 110 368 | 0 | 0 | $0 |
| John Peter Mclaughlin | Administrateur | 25 mai 2023 A | 53 631 | 0 | 0 | $0 |
| PDL BIOPHARMA, INC. | Détenteur de 10% | 1 octobre 2020 J | 0 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 5 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 32 301 SH | 11 septembre 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,00% | 16 558 NS | 31 juillet 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 114 491 SH | 19 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 275 971 SH | 19 août 2026 | Quotidien |
| DCOR · Dimensional ETF Trust | 0,00% | 4 NS | 31 juillet 2026 | N-PORT |
LNSR Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 8 analystes
ACHAT
Objectif médian
$11.00
+63,0%
3 37,5%
Achat fort
4 50,0%
Achat
1 12,5%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
3 analystes · 2026-10-03Objectif moyen $11.33 +67,9%
← En dessous de tous les objectifs
Prix actuel $6.75
Bas$10.00
Moyenne$11.33
Haut$13.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| LNSR | · | -4.1 | 9.2% | · | · | · |
| ECOR | $36M | -2.7 | 27.2% | -43.6% | 4686.6% | 86.8% |
| HYPR | · | -2.3 | 5.2% | -262.3% | -93.5% | 49.8% |
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| MBOT | $134M | -6.9 | · | · | -24.4% | · |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| VANI | $94M | -2.9 | · | · | -257.8% | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 13, 2026